These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24636680)

  • 1. [Treatment of adrenal deficiency: To what issues? By which therapeutic means?].
    Reznik Y
    Presse Med; 2014 Apr; 43(4 Pt 1):438-43. PubMed ID: 24636680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of adrenal insufficiency in different clinical settings.
    Hahner S; Allolio B
    Expert Opin Pharmacother; 2005 Nov; 6(14):2407-17. PubMed ID: 16259572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapies for adrenal insufficiency.
    Oki K; Yamane K
    Expert Opin Pharmacother; 2007 Jun; 8(9):1283-91. PubMed ID: 17563263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M; Gryczyńska M; Sowińska A; Sowiński J
    Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Management and Outcome of Pregnancies in Women With Adrenal Insufficiency: Experience from a Multicenter Survey.
    Bothou C; Anand G; Li D; Kienitz T; Seejore K; Simeoli C; Ebbehoj A; Ward EG; Paragliola RM; Ferrigno R; Badenhoop K; Bensing S; Oksnes M; Esposito D; Bergthorsdottir R; Drake W; Wahlberg J; Reisch N; Hahner S; Pearce S; Trainer P; Etzrodt-Walter G; Thalmann SP; Sævik ÅB; Husebye E; Isidori AM; Falhammar H; Meyer G; Corsello SM; Pivonello R; Murray R; Bancos I; Quinkler M; Beuschlein F
    J Clin Endocrinol Metab; 2020 Aug; 105(8):e2853-63. PubMed ID: 32424397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
    Charmandari E; Calis KA; Keil MF; Mohassel MR; Remaley A; Merke DP
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3197-200. PubMed ID: 12107224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study.
    Puglisi S; Rossini A; Tabaro I; Cannavò S; Ferrau' F; Ragonese M; Borretta G; Pellegrino M; Dughera F; Parisi A; Latina A; Pia A; Terzolo M; Reimondo G
    J Endocrinol Invest; 2021 Apr; 44(4):865-872. PubMed ID: 32779106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
    Lennernäs H; Skrtic S; Johannsson G
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
    Isidori AM; Venneri MA; Graziadio C; Simeoli C; Fiore D; Hasenmajer V; Sbardella E; Gianfrilli D; Pozza C; Pasqualetti P; Morrone S; Santoni A; Naro F; Colao A; Pivonello R; Lenzi A
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):173-185. PubMed ID: 29229498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.
    Johannsson G; Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Olsson T; Ragnarsson O; Ryberg M; Wahlberg J; Biller BM; Monson JP; Stewart PM; Lennernäs H; Skrtic S
    J Clin Endocrinol Metab; 2012 Feb; 97(2):473-81. PubMed ID: 22112807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of plasma renin activity in evaluating the adequacy of mineralocorticoid replacement in primary adrenal insufficiency.
    Flad TM; Conway JD; Cunningham SK; McKenna TJ
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):529-34. PubMed ID: 8977748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel strategies for hydrocortisone replacement.
    Debono M; Price JN; Ross RJ
    Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):221-32. PubMed ID: 19500765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
    Harbeck B; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
    Johannsson G; Lennernäs H; Marelli C; Rockich K; Skrtic S
    Eur J Endocrinol; 2016 Jul; 175(1):85-93. PubMed ID: 27129362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary adrenal insufficiency: from the physiopathology to the possible role of modified-release hydrocortisone treatment.
    Paragliola RM; Corsello SM
    Minerva Endocrinol; 2018 Jun; 43(2):183-197. PubMed ID: 28750490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal insufficiency.
    Arlt W
    Clin Med (Lond); 2008 Apr; 8(2):211-5. PubMed ID: 18478875
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydrocortisone for adrenal insufficiency.
    Elder CJ; Dimitri P
    Arch Dis Child Educ Pract Ed; 2015 Oct; 100(5):272-6. PubMed ID: 25561746
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse effect of phenytoin on mineralocorticoid replacement with fludrocortisone in adrenal insufficiency.
    Keilholz U; Guthrie GP
    Am J Med Sci; 1986 Apr; 291(4):280-3. PubMed ID: 3706393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiometabolic and psychological effects of dual-release hydrocortisone: a cross-over study.
    Dineen R; Martin-Grace J; Ahmed KMS; Frizelle I; Gunness A; Garrahy A; Hannon AM; O'Reilly MW; Smith D; McDermott J; Healy ML; Agha A; Pazderska A; Gibney J; Thompson CJ; Behan LA; Sherlock M
    Eur J Endocrinol; 2021 Feb; 184(2):253-265. PubMed ID: 33513125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.